Strongly agree about many of these points. I think it’s worth looking at our earlier post, and the paper we wrote on almost exactly this topic which we worked on in 2019 - which obviously aren’t focused on post-COVID-19 ideas.
On objections to trials, there is a large literature about the difficulty of assessing the impact of interventions, from Pearl’s fundamental argument, here (pdf), to the entire corpus of work on generalizability and transferability in practice.
I think that further development of the suggested potential projects would be valuable—if you agree, I’d be happy to discuss how to turn them into more concrete proposals. Though in fact, many of these have already been done—a literature review (post is strongly recommended reading!) would probably find many pieces like this one that address many of your points.
Strongly agree about many of these points. I think it’s worth looking at our earlier post, and the paper we wrote on almost exactly this topic which we worked on in 2019 - which obviously aren’t focused on post-COVID-19 ideas.
On objections to trials, there is a large literature about the difficulty of assessing the impact of interventions, from Pearl’s fundamental argument, here (pdf), to the entire corpus of work on generalizability and transferability in practice.
I think that further development of the suggested potential projects would be valuable—if you agree, I’d be happy to discuss how to turn them into more concrete proposals. Though in fact, many of these have already been done—a literature review (post is strongly recommended reading!) would probably find many pieces like this one that address many of your points.